-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
DiaMedica Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2024.
- DiaMedica Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$6.65M, a 30.7% decline year-over-year.
- DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$18.7M, a 62.7% decline from 2022.
- DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$11.5M, a 6.05% increase from 2021.
- DiaMedica Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$12.3M, a 33.4% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)